Latest News

Each news article below shows only part of the news story. To view the full story, click on Read More below the story. 

  • November 21, 2018 8:36 AM | Anonymous

    November 21, 2018, Medscape  

    The overall infant mortality rate in the United States did not change much from 2011 through 2016, after declining 10 percent from 2007 through 2011, according to new data from the National Center for Health Statistics (NCHS) of the Centers for Disease Control and Prevention (CDC).

    Read more.

  • November 21, 2018 8:33 AM | Anonymous
    November 21, 2018, News Medical  

    Using technology similar to the type that powers facial and speech recognition on a smartphone, researchers at the University of North Carolina Lineberger Comprehensive Cancer Center have trained a computer to analyze breast cancer images and then classify the tumors with high accuracy.  

    Read more.

  • November 20, 2018 7:32 AM | Anonymous

    November 20, 2018, MedPage Today  

    Results of preliminary studies evaluating immune checkpoint inhibitors in ovarian cancer are good, but there are ways to make them better, experts said.

    "The first published experience in ovarian cancer shows very promising results and a much higher efficacy than expected from previously known mono-immunotherapeutics like vaccines or immuno-stimulants, but the positive results do not compare with the extraordinary results in other entities like melanoma, where checkpoint inhibition changed the game," said Klaus Pietzner, MD, of Charité-University Medicine in Berlin, and colleagues.

    Read more.
  • November 19, 2018 8:10 AM | Anonymous

    November 19, 2018, Medgadget  

    Researchers at Washington University in St. Louis have developed a diagnostic method involving photoacoustic imaging, a technique that combines ultrasound and laser light. The development may allow clinicians to diagnose ovarian cancer earlier, helping to save lives.  

    Read more.

  • November 14, 2018 2:43 PM | Anonymous

    Rachel Ditoro, PA-C presented "Managing Menopause" on Tuesday, November 13, 2018. Click here to view her presentation in our webinar library. Thank you again Rachel! 

  • November 14, 2018 1:58 PM | Anonymous

    November 14, 2018

    APAOG is proud to share this American Institute of Ultrasound in Medicine (AIUM) Practice Parameter for the Performance of Limited Obstetric Ultrasound Examinations by Advanced Practice Providers publication. APAOG Board members Aleece Fosnight, PA-C (President) and Kristen Lohser, PA-C (Vice-President) contributed to this publication on behalf of APAOG. 

    This practice parameter has been developed for use by women’s health nurse practitioners (WHNPs), physician assistants in obstetrics and gynecology (PAOGs), and certified nurse-midwives (CNMs)/certified midwives (CMs) performing and interpreting limited obstetric ultrasound studies within their scopes of practice.

    Also in conjunction with AIUM and APAOG were the following organizations: National Association of Nurse Practitioners in Women’s Health (NPWH), American College of Nurse-Midwives (ACNM), American College of Obstetricians and Gynecologists (ACOG), American College of Osteopathic Obstetricians and Gynecologists (ACOOG), and the Society for Maternal-Fetal Medicine (SMFM).

    Access the Practice Parameter Publication here.

  • November 14, 2018 1:25 PM | Anonymous

    November 14, 2018, HemOnc Today  

    Women with early-stage cervical cancer who underwent minimally invasive radical hysterectomy had higher rates of recurrence and worse survival outcomes than women who had open surgery, according to results of two studies published in The New England Journal of Medicine. 

    Read more.

  • November 09, 2018 11:24 AM | Anonymous
    November 9, 2018, Medscape 

    A single oral dose of the investigational antibiotic zoliflodacin performs as well as intramuscular ceftriaxone (Rocephin, Hoffman-LaRoche) for treatment of uncomplicated urogenital and rectal gonococcal infections, a multicenter phase 2 trial suggests. 

    Read more.

  • November 07, 2018 8:41 AM | Anonymous

    November 7, 2018, MedPage Today 

    Women who started taking a statin at the age of 50 or older had a significantly lower risk of developing any histologic type of ovarian cancer over the next decade than non-statin users did, according to a large, case-control study. The study by Daniel Cramer, MD, of Harvard Medical School in Boston, and colleagues also found that the effect was independent of use of any other concomitant medication. 

    Read more.

  • November 05, 2018 8:28 AM | Anonymous
    November 5, 2018, MedPage Today 

    Women who test negative for human papillomavirus (HPV) at or after age 55 can likely forego cervical cancer screening for the rest of their lives, a new modeling study suggests. Although the risk for cervical cancer later in life could be decreased by screening women until age 75, the study model showed that women who test HPV DNA negative to 14 high-risk HPV types and stop screening at 55 have a remaining lifetime cervical cancer risk of less than 1 percent, reported Talia Malagon, PhD, of McGill University in Montreal, and colleagues in Lancet Oncology.  

    Read more.

Powered by Wild Apricot Membership Software